Comorbidities in Ankylosing Spondylitis

RT @RichardPAConway: Rhee @RennieRhee et al. Combined cranial vessel wall and orbital MRI for GCA. Improves sensitivity

Tweet Author

Tweet Content

Rhee @RennieRhee et al. Combined cranial vessel wall and orbital MRI for GCA. Improves sensitivity 77% vs 69% with loss of specificity 91% vs 95%. Identifies abnormalities in some without visual symptoms - at risk of vision loss @RheumNow #ACR22 Abstr#1618 https://t.co/OtGm7sEWtU https://t.co/YM4WLahubH

Links

Combined Orbital and Cranial Vessel Wall MRI for Diagnosis and Longitudinal Mon… https://acrabstracts.org/abstract/combined-orbital-and-cranial-vessel-wall-mri-…

RT @Yuz6Yusof: #ACR22 Abstr#2055 SRI-4 and BICLA: how do they converge and diverge? Analyses of 6 x Non-Renal #Lupus RCT

Tweet Author

Yuz6Yusof

Tweet Content

#ACR22 Abstr#2055 SRI-4 and BICLA: how do they converge and diverge? Analyses of 6 x Non-Renal #Lupus RCT showed discordance (12-30%).When discordant, SRI-4 classified more pts as responders vs BICLA. Concordance higher at 52 vs 24 wks. Vital to interpret both outcomes @RheumNow https://t.co/prSfTrv0E8

RT @RichardPAConway: Charlton et al PsA patients face longer diagnostic delay and less intensive treatment than RA patie

Tweet Author

RichardPAConway

Tweet Content

Charlton et al PsA patients face longer diagnostic delay and less intensive treatment than RA patients for equivalent disease activity. @RheumNow #ACR22 Abstr#1613 https://t.co/HedK59QsKs https://t.co/xaJUy7w1t4

Links

Diagnostic Delay and Less Intensive Therapy for People with Psoriatic Arthritis… https://acrabstracts.org/abstract/diagnostic-delay-and-less-intensive-therapy-f…

RT @RichardPAConway: Karmacharya @rheum_cat et al. Comorbidity clusters in AS. Depression cluster associated higher dise

Tweet Author

RichardPAConway

Tweet Content

Karmacharya @rheum_cat et al. Comorbidity clusters in AS. Depression cluster associated higher disease activity and worse function over time. @RheumNow #ACR22 Abstr#1609 https://t.co/lFVoyhy5UQ https://t.co/26EjzXULGr

Links

Comorbidity Clusters in Ankylosing Spondylitis and Their Association with Disea… https://acrabstracts.org/abstract/comorbidity-clusters-in-ankylosing-spondyliti…

RT @AkhilSoodMD: The pandemic has brought many challenges to our community. One of them is the lingering effects of COVI

Tweet Author

AkhilSoodMD

Tweet Content

The pandemic has brought many challenges to our community. One of them is the lingering effects of COVID-19. #PASC #COVID #ACR22 #RheumTwitter https://t.co/AlwUHX2cao

Links

Long COVID and Rheumatic Disease | RheumNow https://rheumnow.com/news/long-covid-and-rheumatic-disease

RT @synovialjoints: Spinal lesions on MRI in axSpA is ~3% in patients with negative imaging in SIJ on MRI or X-ray. Agre

Tweet Author

synovialjoints

Tweet Content

Spinal lesions on MRI in axSpA is ~3% in patients with negative imaging in SIJ on MRI or X-ray. Agreement in >5/9 central readers. Frequency of spinal vertebral corner BME lesions was significantly higher these cases. Maksymovych Abs#2257 https://t.co/56yxGxBgLp #ACR22 @RheumNow https://t.co/CkJ9o2dJuT

Links

MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacro… http://bit.ly/3UAj6Nk

RT @RichardPAConway: Mease et al. TYK2i Deucravacitinib in PsA. Phase 2 RCT 52 week results. PASDAS, DAPSA efficacy main

Tweet Author

RichardPAConway

Tweet Content

Mease et al. TYK2i Deucravacitinib in PsA. Phase 2 RCT 52 week results. PASDAS, DAPSA efficacy maintained through week 52. No new safety concerns. @RheumNow #ACR22 Abstr#1598 https://t.co/sRKkgkYtQJ https://t.co/YMXMEH3wsq

Links

Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 In… https://acrabstracts.org/abstract/safety-and-efficacy-of-deucravacitinib-an-ora…

RT @RichardPAConway: Ogdie @AlexisOgdie et al. CorEvitas, PsA treatment after 1st line TNFi failure. Switching MOA proba

Tweet Author

RichardPAConway

Tweet Content

Ogdie @AlexisOgdie et al. CorEvitas, PsA treatment after 1st line TNFi failure. Switching MOA probably more effective @RheumNow #ACR22 Abstr#1600 https://t.co/vy8gxDaYxZ https://t.co/NmkESbSNfL

Links

The Impact of Second-Line Therapeutic on Disease Control After Discontinuation … https://acrabstracts.org/abstract/the-impact-of-second-line-therapeutic-on-dise…

RT @Yuz6Yusof: #ACR22 Abstr#1764 In addition to race, what social health aspect to consider when assessing #lupus epidem

Tweet Author

Yuz6Yusof

Tweet Content

#ACR22 Abstr#1764 In addition to race, what social health aspect to consider when assessing #lupus epidemiology? A study identified urbanicity and area deprivation index were associated with SLE diagnosis. Could those living in the city = better access and diagnosis? @RheumNow https://t.co/PsNt8vQufs

Topics

Comorbidities in Ankylosing Spondylitis

RT @RichardPAConway: Rhee @RennieRhee et al. Combined cranial vessel wall and orbital MRI for GCA. Improves sensitivity

RT @Yuz6Yusof: #ACR22 Abstr#2055 SRI-4 and BICLA: how do they converge and diverge? Analyses of 6 x Non-Renal #Lupus RCT

RT @RichardPAConway: Charlton et al PsA patients face longer diagnostic delay and less intensive treatment than RA patie

RT @RichardPAConway: Karmacharya @rheum_cat et al. Comorbidity clusters in AS. Depression cluster associated higher dise

RT @AkhilSoodMD: The pandemic has brought many challenges to our community. One of them is the lingering effects of COVI

RT @synovialjoints: Spinal lesions on MRI in axSpA is ~3% in patients with negative imaging in SIJ on MRI or X-ray. Agre

RT @RichardPAConway: Mease et al. TYK2i Deucravacitinib in PsA. Phase 2 RCT 52 week results. PASDAS, DAPSA efficacy main

RT @RichardPAConway: Ogdie @AlexisOgdie et al. CorEvitas, PsA treatment after 1st line TNFi failure. Switching MOA proba

RT @Yuz6Yusof: #ACR22 Abstr#1764 In addition to race, what social health aspect to consider when assessing #lupus epidem

Do you get our email newsletter?